USA flag logo/image

An Official Website of the United States Government

Novel Skin Barrier to Prevent and Treat Poison Ivy

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
71311
Program Year/Program:
2004 / STTR
Agency Tracking Number:
AR051618
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIOMEDICAL DEVELOPMENT CORPORATION
A152 ASTeCC Building Lexington, KY 40506-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2004
Title: Novel Skin Barrier to Prevent and Treat Poison Ivy
Agency: HHS
Contract: 1R41AR051618-01
Award Amount: $133,731.00
 

Abstract:

DESCRIPTION (provided by applicant): Poison ivy/oak dermatitis (also known as Toxicodendron dermatitis) is the most common allergic contact dermatitis in the United States, affecting millions of Americans every year. The prevalence of poison ivy and oak sensitivity in the general adult population ranges from 50 to 70%, and the sensitivity and severity of skin inflammation can range from minor irritation to that which requires medical attention. Topical corticosteroids are the main form of treatment for poison ivy/oak irritations, however the tendency to develop secondary infection can be enhanced by the use of topical or systemic corticosteroids. The goal of this project is to evaluate a patented polymer-based coating technology as both a skin barrier to and treatment for poison ivy and poison oak dermatitis. The innovative coating is expected to provide a safe, antimicrobial, anti-inflammatory skin barrier product that may prevent and treat poison ivy/oak dermatitis. In order to demonstrate feasibility and effectiveness of using the coatings as a barrier and treatment, the following Specific Aims will be pursued: 1. Optimize Coating Formulations and Compound Formulations for Clinical Testing 2. Evaluate Coatings as a Skin Barrier and Treatment for Toxicodendron Dermatitis in Humans

Principal Investigator:

H. R. Rawls
2105676871
rawls@uthscsa.edu

Business Contact:

Gregg Siegel
2103080636
GSIEGEL@BIODEVCORP.COM
Small Business Information at Submission:

BIOMEDICAL DEVELOPMENT CORPORATION
BIOMEDICAL DEVELOPMENT CORP 500 SANDAU, STE 200 SAN ANTONIO, TX 78216

EIN/Tax ID: 742330067
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
UNIVERSITY OF TEXAS HLTH SCI CTR
SAN ANTONIO, TX 78229
RI Type: Nonprofit college or university